Free Trial

Sintx Technologies (SINT) Competitors

Sintx Technologies logo
$3.75 +0.29 (+8.38%)
Closing price 04:00 PM Eastern
Extended Trading
$3.58 -0.18 (-4.67%)
As of 06:24 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

SINT vs. CTSO, TELA, ICCM, BDMD, SURG, SRTS, PYPD, APT, TMDIF, and NMTC

Should you be buying Sintx Technologies stock or one of its competitors? The main competitors of Sintx Technologies include Cytosorbents (CTSO), TELA Bio (TELA), IceCure Medical (ICCM), Baird Medical Investment (BDMD), SurgePays (SURG), Sensus Healthcare (SRTS), PolyPid (PYPD), Alpha Pro Tech (APT), Titan Medical (TMDIF), and NeuroOne Medical Technologies (NMTC). These companies are all part of the "medical equipment" industry.

Sintx Technologies vs. Its Competitors

Sintx Technologies (NASDAQ:SINT) and Cytosorbents (NASDAQ:CTSO) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, risk, media sentiment, valuation, institutional ownership, profitability, analyst recommendations and dividends.

Sintx Technologies presently has a consensus target price of $25.00, suggesting a potential upside of 566.67%. Cytosorbents has a consensus target price of $5.50, suggesting a potential upside of 546.91%. Given Sintx Technologies' higher possible upside, equities analysts clearly believe Sintx Technologies is more favorable than Cytosorbents.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Sintx Technologies
1 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00
Cytosorbents
1 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00

Sintx Technologies has higher earnings, but lower revenue than Cytosorbents. Cytosorbents is trading at a lower price-to-earnings ratio than Sintx Technologies, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Sintx Technologies$2.89M4.66-$11.02M-$50.56-0.07
Cytosorbents$36.11M1.48-$20.72M-$0.17-5.00

In the previous week, Sintx Technologies had 6 more articles in the media than Cytosorbents. MarketBeat recorded 7 mentions for Sintx Technologies and 1 mentions for Cytosorbents. Sintx Technologies' average media sentiment score of 0.70 beat Cytosorbents' score of 0.00 indicating that Sintx Technologies is being referred to more favorably in the media.

Company Overall Sentiment
Sintx Technologies Positive
Cytosorbents Neutral

Sintx Technologies has a beta of 0.83, indicating that its stock price is 17% less volatile than the S&P 500. Comparatively, Cytosorbents has a beta of 1.28, indicating that its stock price is 28% more volatile than the S&P 500.

18.4% of Sintx Technologies shares are held by institutional investors. Comparatively, 32.9% of Cytosorbents shares are held by institutional investors. 4.1% of Sintx Technologies shares are held by insiders. Comparatively, 7.3% of Cytosorbents shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Cytosorbents has a net margin of -25.58% compared to Sintx Technologies' net margin of -674.05%. Cytosorbents' return on equity of -111.97% beat Sintx Technologies' return on equity.

Company Net Margins Return on Equity Return on Assets
Sintx Technologies-674.05% -256.59% -121.32%
Cytosorbents -25.58%-111.97%-29.00%

Summary

Cytosorbents beats Sintx Technologies on 8 of the 14 factors compared between the two stocks.

Get Sintx Technologies News Delivered to You Automatically

Sign up to receive the latest news and ratings for SINT and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SINT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SINT vs. The Competition

MetricSintx TechnologiesMED INSTRUMENTS IndustryMedical SectorNASDAQ Exchange
Market Cap$13.46M$7.59B$6.14B$10.76B
Dividend YieldN/A1.13%5.71%4.83%
P/E Ratio-0.0727.3629.8028.54
Price / Sales4.6628.19499.06189.72
Price / CashN/A22.5936.6160.67
Price / Book1.295.2612.016.61
Net Income-$11.02M$178.09M$3.32B$276.82M
7 Day Performance-5.30%1.09%1.78%2.07%
1 Month Performance-23.63%2.00%6.28%2.62%
1 Year Performance17.92%5.13%61.13%32.86%

Sintx Technologies Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SINT
Sintx Technologies
2.6998 of 5 stars
$3.75
+8.4%
$25.00
+566.7%
+3.0%$13.46M$2.89M-0.0740Short Interest ↓
Gap Down
CTSO
Cytosorbents
1.4115 of 5 stars
$0.93
-0.5%
$5.50
+494.6%
-19.8%$58.05M$35.60M-5.44220
TELA
TELA Bio
2.1762 of 5 stars
$1.47
-2.3%
$4.50
+207.2%
-43.8%$58.04M$69.30M-1.31120
ICCM
IceCure Medical
2.1854 of 5 stars
$0.83
-1.5%
$2.64
+217.1%
+46.5%$57.09M$3.29M-5.1960
BDMD
Baird Medical Investment
N/A$1.55
-1.3%
N/A-53.3%$55.36MN/A0.00N/AShort Interest ↑
Gap Up
SURG
SurgePays
2.0728 of 5 stars
$2.70
-0.2%
$9.50
+252.5%
+55.1%$55.04M$60.88M-1.0840
SRTS
Sensus Healthcare
2.295 of 5 stars
$3.22
+0.2%
$8.00
+148.8%
-48.1%$52.86M$41.81M-53.5840News Coverage
Analyst Upgrade
PYPD
PolyPid
3.6088 of 5 stars
$3.28
-1.8%
$12.40
+278.0%
+4.6%$52.15MN/A-0.8680Positive News
Short Interest ↓
APT
Alpha Pro Tech
N/A$4.76
+1.3%
N/A-22.8%$49.84M$58.56M12.86120
TMDIF
Titan Medical
N/A$0.43
flat
N/A-47.1%$49.39M$17.63M-0.3550Gap Up
NMTC
NeuroOne Medical Technologies
1.7951 of 5 stars
$0.92
+2.2%
$2.23
+141.8%
-16.3%$46M$3.45M-6.1320News Coverage
Short Interest ↑

Related Companies and Tools


This page (NASDAQ:SINT) was last updated on 10/24/2025 by MarketBeat.com Staff
From Our Partners